American Century Companies Inc Recursion Pharmaceuticals, Inc. Transaction History

American Century Companies Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$9.13 - $15.52 $141,186 - $240,001	-15,464 Reduced 55.63%	12,334 $122,000
Q4 2023 Feb 13, 2024	BUY	$5.09 - $10.79 $141,491 - $299,940	27,798 New	27,798 $274,000
Q3 2023 Nov 13, 2023	BUY	$6.59 - $15.86 $498,942 - $1.2 Million	75,712 Added 741.33%	85,925 $657,000
Q2 2023 Aug 14, 2023	BUY	$4.56 - $9.94 $46,571 - $101,517	10,213 New	10,213 $76,000
Q2 2022 Aug 12, 2022	SELL	$5.04 - $9.26 $1.52 Million - $2.8 Million	-301,984 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$6.16 - $18.03 $6,572 - $19,238	-1,067 Reduced 0.35%	301,984 $2.16 Million
Q4 2021 Feb 07, 2022	BUY	$16.14 - $21.86 $2.45 Million - $3.32 Million	151,692 Added 100.22%	303,051 $5.19 Million
Q3 2021 Nov 10, 2021	BUY	$19.03 - $41.33 $2.88 Million - $6.26 Million	151,359 New	151,359 $3.48 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.31B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.